• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间的病毒动力学模型:我们是否为下一次大流行做好准备?

Viral Dynamic Models During COVID-19: Are We Ready for the Next Pandemic?

作者信息

Marc Aurelien, Schiffer Joshua T, Mentré France, Perelson Alan S, Guedj Jérémie

机构信息

T-6, Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2025 Aug;14(8):1289-1297. doi: 10.1002/psp4.70055. Epub 2025 Jun 2.

DOI:10.1002/psp4.70055
PMID:40457567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12358307/
Abstract

Mathematical models have been used for about 30 years to improve our understanding of virus-host interaction, in particular during chronic infections. During the COVID-19 pandemic, these models have been used to provide insights into the natural history of acute SARS-CoV-2 infection, optimize antiviral treatment strategies, understand factors associated with transmission, and optimize surveillance systems. The impact of modeling has been accelerated by the availability of unprecedented multidimensional immune data from animal and human systems, which enhanced partnerships between experimentalists and theorists and led to exciting new modeling and statistical developments. In this mini review, we examine the lessons learned from the COVID-19 pandemic and discuss the main insights provided by mathematical models of viral dynamics at the different stages of the outbreak. Although we focus on respiratory infection, we also consider the new areas for development in anticipation of future acute infections from new or reemerging pathogens.

摘要

数学模型已被使用约30年,以增进我们对病毒与宿主相互作用的理解,尤其是在慢性感染期间。在新冠疫情期间,这些模型被用于深入了解急性SARS-CoV-2感染的自然史、优化抗病毒治疗策略、理解与传播相关的因素以及优化监测系统。动物和人类系统中前所未有的多维免疫数据的可用性加速了建模的影响,这加强了实验人员和理论家之间的合作,并带来了令人兴奋的新建模和统计进展。在这篇小型综述中,我们审视了从新冠疫情中学到的经验教训,并讨论了疫情不同阶段病毒动力学数学模型提供的主要见解。尽管我们专注于呼吸道感染,但我们也考虑了预期未来由新出现或重新出现的病原体引发的急性感染的新发展领域。

相似文献

1
Viral Dynamic Models During COVID-19: Are We Ready for the Next Pandemic?新冠疫情期间的病毒动力学模型:我们是否为下一次大流行做好准备?
CPT Pharmacometrics Syst Pharmacol. 2025 Aug;14(8):1289-1297. doi: 10.1002/psp4.70055. Epub 2025 Jun 2.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
Significance of supervision sampling in control of communicable respiratory disease simulated by a new model during different stages of the disease.新模型模拟的呼吸道传染病不同阶段中监督抽样在疾病控制中的意义。
Sci Rep. 2025 Jan 30;15(1):3787. doi: 10.1038/s41598-025-86739-9.
5
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
8
Short-Term Memory Impairment短期记忆障碍
9
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
10
Service Interruption in HIV Care Amid COVID-19 Pandemic in Myanmar: Results From Analysis of Routine Program Data 2018-2022.缅甸新冠疫情期间艾滋病护理服务中断情况:2018 - 2022年常规项目数据分析结果
J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241299466. doi: 10.1177/23259582241299466.

本文引用的文献

1
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.模型表明,奈玛特韦-利托那韦治疗后SARS-CoV-2的反弹是由靶细胞保留以及病毒清除不完全共同驱动的。
J Virol. 2025 Mar 18;99(3):e0162324. doi: 10.1128/jvi.01623-24. Epub 2025 Feb 4.
2
The kinetics of SARS-CoV-2 infection based on a human challenge study.基于人体挑战研究的 SARS-CoV-2 感染动力学。
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2406303121. doi: 10.1073/pnas.2406303121. Epub 2024 Nov 7.
3
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.
Evusheld 对感染前奥密克戎或奥密克戎变异株的 COVID-19 住院患者的抗病毒效果:一项随机 DisCoVeRy 试验的建模分析。
J Antimicrob Chemother. 2024 Nov 4;79(11):2887-2895. doi: 10.1093/jac/dkae301.
4
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy.一种统一的模型来解释奈玛特韦治疗后 SARS-CoV-2 频繁反弹和有限的预防效果。
Nat Commun. 2024 Jun 28;15(1):5478. doi: 10.1038/s41467-024-49458-9.
5
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).SARS-CoV-2 清除动力学的时间变化和抗病毒药效学研究的最佳设计:一项随机、对照、自适应平台研究(PLATCOV)的个体患者数据分析荟萃分析。
Lancet Infect Dis. 2024 Sep;24(9):953-963. doi: 10.1016/S1473-3099(24)00183-X. Epub 2024 Apr 24.
6
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.模拟抗刺突单克隆抗体治疗期间 SARS-CoV-2 病毒耐药性的出现。
PLoS Pathog. 2024 Apr 18;20(4):e1011680. doi: 10.1371/journal.ppat.1011680. eCollection 2024 Apr.
7
How robust are estimates of key parameters in standard viral dynamic models?标准病毒动力学模型中关键参数估计的稳健性如何?
PLoS Comput Biol. 2024 Apr 16;20(4):e1011437. doi: 10.1371/journal.pcbi.1011437. eCollection 2024 Apr.
8
Modeling how antibody responses may determine the efficacy of COVID-19 vaccines.模拟抗体反应如何决定新冠疫苗的疗效。
Nat Comput Sci. 2022 Feb;2(2):123-131. doi: 10.1038/s43588-022-00198-0. Epub 2022 Feb 28.
9
Correction to Lancet Infect Dis 2023; published online Sept 28. https://doi.org/10.1016/S1473-3099(23)00493-0.《柳叶刀·传染病学》2023年勘误;9月28日在线发表。https://doi.org/10.1016/S1473-3099(23)00493-0 。
Lancet Infect Dis. 2023 Dec;23(12):e511. doi: 10.1016/S1473-3099(23)00649-7. Epub 2023 Oct 12.
10
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis.中和抗体水平作为预防 SARS-CoV-2 感染的保护相关因素:建模分析。
Clin Pharmacol Ther. 2024 Jan;115(1):86-94. doi: 10.1002/cpt.3069. Epub 2023 Oct 20.